Prospective Clinical Evaluation of BD Spinal Needles

NCT ID: NCT05214560

Last Updated: 2024-08-19

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

160 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-02-14

Study Completion Date

2022-07-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Post-market, observational study to assess the real-world safety and efficacy of BD Spinal Needles used in an on-market fashion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Single-arm, post-market, observational, prospective study of participants who will receive neuraxial procedures with a BD Spinal Needle as part of their routine medical care.

Patients will be followed from BD Spinal needle insertion up to 7 days after the insertion according to the routine medical care and site policy.

Data collected will be gathered from the patient's medical charts.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Analgesia Anesthesia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

All participants

Participants who require a BD Spinal needle

Spinal needle

Intervention Type DEVICE

Insertion of a spinal needle to perform the neuraxial procedure.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Spinal needle

Insertion of a spinal needle to perform the neuraxial procedure.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any patient, regardless of age or gender, for which the investigator has decided that a neuraxial procedure must be performed utilizing BD Spinal Needles as part of their routine medical care
* Expected to be available for observation through the study period (7-days post procedure)
* Provision of signed and dated informed consent form (Note: Consent of guardian or parent may be required for patients under the age of 18 years; participant assent may be required as well.)

Exclusion Criteria

* Undergoing emergency surgery
* Coagulopathy or bleeding disorder for which regional anesthesia poses an increased risk
* History of neurological impairment or disease of the trunk or lower extremities.
* Infection at or near the site of needle insertion
* Previous spine surgery at the level involved in the study procedure
Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Cromsource

INDUSTRY

Sponsor Role collaborator

Becton, Dickinson and Company

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Klaus Hoerauf, MD

Role: STUDY_DIRECTOR

Becton, Dickinson and Company

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Medizinische Universität Wien

Vienna, , Austria

Site Status

Sejnjoen Central Hospital

Seinäjoki, , Finland

Site Status

Charité Campus Benjamin Franklin

Berlin, , Germany

Site Status

Universitätsklinikum Leipzig

Leipzig, , Germany

Site Status

Hospital Universitario Quirónsalud Madrid

Madrid, , Spain

Site Status

Schulthess Klinik, Zürich

Zurich, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Austria Finland Germany Spain Switzerland

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol

View Document

Document Type: Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MDS-20EPSPEU001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Restore Claims Characterization Study
NCT00200122 COMPLETED PHASE4
Spinal Cord Stimulation for Low Back Pain
NCT00205868 COMPLETED PHASE4